Data Protection: Addressing Noise, Speech, and Voice Concerns

Here's our newest conversation with Brij Mohan Lal Srivastava, CEO and Co-founder of Nijta, a company at the forefront of AI in speech anonymization. The realm of voice is an emerging and fascinating area within the life sciences, and with every new domain, issues of privacy come to the forefront.

In this discussion, we converse with Brij Mohan Lal Srivastava, who is the co-founder and CEO of Nijta, a company that focuses on developing AI-powered solutions for data anonymization and pseudonymization. These solutions are becoming increasingly important in clinical research, particularly with the emergence of voice as an important biomarker for identifying diseases such as depression. We delve into the fundamentals of noise, speech, and voice, and also explore how Nijta's technologies can be applied in the life sciences sector.

Link to the video

Seamus Larroque

CDPO / CPIM / ISO 27005 Certified


Discover our latest articles

View All Blog Posts
April 23, 2024
No items found.

iliomad is deligthed to have supported the ICM - Institut du Cancer de Montpellier in their CNIL's authorization process

We are delighted to share that the ICM - Institut du Cancer de Montpellier was authorized by the French Data Protection Authority (CNIL) to conduct APAD-ECO study. The CNIL granted authorization to conduct a medico-economic study on the effects of physical activity in women treated for breast cancer on April, 19th. This groundbreaking study involves combining data from two clinical trials with that of the Caisse nationale de l’Assurance Maladie, covering the period from 2009 to 2022. The study aims to assess the long-term impacts of physical activity in patients who have undergone treatment for breast cancer. We are proud to have contributed to this project by providing the ICM - Institut du Cancer de Montpellier with a compliant Data Protection Impact Assessment (DPIA), a crucial step in obtaining CNIL approval.